Indigo Ag and Truterra launch strategic collaboration to accelerate adoption of agriculture sustainability solutions

Tessera Therapeutics Presents New Preclinical Data in In Vivo AATD and SCD Programs at the 31st Annual Congress of the European Society of Gene and Cell Therapy

Startup led by John Maraganore raises $135M to build ‘future of RNAi’

Novartis inks $1B-plus biobucks deal with Flagship's Generate

Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual

Incyte Completes Acquisition of Escient Pharmaceuticals

Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M

Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction

Encoded Therapeutics Announces US IND Clearance and Australian CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101

eFFECTOR Therapeutics Announces New Positive Interim Data from Dose Escalation and Phase 2 Expansion